Datavault AI Expands Healthcare Data Monetization With DataMeds AI Deal
Datavault AI has amended its licensing agreement with DataMeds AI to cover all commercial healthcare and wellness applications of its data monetization and blockchain IP. The deal grants Datavault AI approximately 19.9% of DataMeds common stock upon closing of several concurrent transactions. ECI Research examines the strategic logic, execution risks, and compliance challenges facing the expanded partnership.
Datavault AI Expands Healthcare Data Monetization With DataMeds AI Deal Read More »










